Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.

Alexander HR, Fraker DL, Norton JA, Bartlett DL, Tio L, Benjamin SB, Doppman JL, Goebel SU, Serrano J, Gibril F, Jensen RT.

Ann Surg. 1998 Aug;228(2):228-38.

2.

Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT.

Ann Surg. 2004 May;239(5):617-25; discussion 626.

3.

Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome.

Ruszniewski P, Amouyal P, Amouyal G, Grangé JD, Mignon M, Bouché O, Bernades P.

Surgery. 1995 Jun;117(6):629-35.

PMID:
7778027
4.
5.

Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome.

Norton JA, Fraker DL, Alexander HR, Jensen RT.

Ann Surg. 2012 Sep;256(3):509-17. doi: 10.1097/SLA.0b013e318265f08d.

6.

A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas.

Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbeyn V, Benya RV, Shawker TH, Doppman JL, Jensen RT.

Ann Surg. 1993 Aug;218(2):138-44.

7.

Somatostatin receptor scintigraphy in gastrinomas.

Jensen RT, Gibril F.

Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S179-85. Review.

PMID:
10604126
8.

Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.

Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, Ruszniewski P, Le Guludec D, Mignon M.

Gastroenterology. 1996 Oct;111(4):845-54.

PMID:
8831579
9.

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.

Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT.

Ann Intern Med. 1996 Jul 1;125(1):26-34.

PMID:
8644985
10.

Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.

Gibril F, Reynolds JC, Chen CC, Yu F, Goebel SU, Serrano J, Doppman JL, Jensen RT.

J Nucl Med. 1999 Apr;40(4):539-53.

11.

Management and outcome of patients with sporadic gastrinoma arising in the duodenum.

Zogakis TG, Gibril F, Libutti SK, Norton JA, White DE, Jensen RT, Alexander HR.

Ann Surg. 2003 Jul;238(1):42-8.

12.

Localization, malignant potential, and surgical management of gastrinomas.

Kisker O, Bastian D, Bartsch D, Nies C, Rothmund M.

World J Surg. 1998 Jul;22(7):651-7; discussion 657-8.

PMID:
9606277
13.

Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management.

Termanini B, Gibril F, Reynolds JC, Doppman JL, Chen CC, Stewart CA, Sutliff VE, Jensen RT.

Gastroenterology. 1997 Feb;112(2):335-47.

PMID:
9024287
14.

[Somatostatin receptor scintigraphy in the primary diagnosis and follow-up care of gastrinoma].

Höring E, Räth U, Rücker S, von Gaisberg U, Meincke J, Walendzik J, Dörr U, Bihl H.

Dtsch Med Wochenschr. 1994 Mar 18;119(11):367-74. German.

PMID:
8131715
15.

Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.

Tonelli F, Giudici F, Nesi G, Batignani G, Brandi ML.

World J Gastroenterol. 2013 Dec 7;19(45):8312-20. doi: 10.3748/wjg.v19.i45.8312. Review.

16.
17.
18.

Gastrinoma: advances in localization and treatment.

Norton JA.

Surg Oncol Clin N Am. 1998 Oct;7(4):845-61. Review.

PMID:
9735137
19.

Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.

Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT.

Ann Surg. 2003 May;237(5):650-7; discussion 657-9.

20.

Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.

Imamura M, Komoto I, Ota S, Hiratsuka T, Kosugi S, Doi R, Awane M, Inoue N.

World J Gastroenterol. 2011 Mar 14;17(10):1343-53. doi: 10.3748/wjg.v17.i10.1343.

Supplemental Content

Support Center